Unveiling The Roles of npcRNA Modulating the Molecular Mechanism of Pathogenic Bacteria Causing Urinary Tract Infections (UTIs)
DOI:
https://doi.org/10.22452/mjs.vol44sp1.5Keywords:
Pathogenic Bacteria, , Multidrug resistance, , non-protein coding RNAs, , Urinary tract Infections (UTIs)Abstract
Urinary tract infections (UTIs) are among the most prevalent and chronic health problems worldwide, impacting millions of individuals annually and posing a substantial financial burden on healthcare systems. UTIs typically initiate when pathogenic bacteria, originating from the gastrointestinal tract, colonize the urethra or periurethral region. Women are more susceptible to UTIs compared to men because of the differences in female lower urinary tract anatomy and its proximity to reproductive organs. The pathogenic bacteria, which are on the World Health Organization (WHO) priority list and cause both uncomplicated and complicated UTIs, are Escherichia coli (UPEC), Klebsiella pneumoniae, Proteus mirabilis, and Staphylococcus aureus. Different therapeutic approaches are necessary to combat UTIs, as seen by the rise in antibiotic resistance in bacteria. Non-protein coding RNAs (npcRNAs) have emerged as promising candidates for regulating genes involved in bacterial pathogenesis and infection, playing a role in modulating gene expression and host-pathogen interactions. By targeting bacterial virulence factors, biofilm formation, and antibiotic resistance mechanisms, npcRNAs provide a novel approach to disrupting infection pathways while minimizing the risk of resistance development.
Downloads
References
Abirami Sanniraj, Suresh V. Chinni, Sumitha Samuggam. (2022). Morphological And Physiological Responses to Npcrna Pmir-137 Knockout in Proteus Mirabilis. Journal of Pharmaceutical Negative Results ;723-9.
Ahsan, A., Zahra, F. T., Asif, A., Fawad , M., Mariam , T., Mazhar , M., Qadeer, A., Yaseen, A., Ilyas, M., & Sharif, M. A. (2024). Antibiotic Resistance and Virulence Genes in Escherichia coli Isolated from Patients in a Tertiary Care Hospital: Implications for Clinical Management and Public Health. BioScientific Review, 6(3), 106-121. https://doi.org/10.32350/bsr.63.07
Al Lawati, H., Blair, B. M., & Larnard, J. (2024). Urinary Tract Infections: Core Curriculum 2024. American Journal of Kidney Diseases, 83(1), 90–100. https://doi.org/10.1053/j.ajkd.2023.08. 009
Ala-Jaakkola, R., Laitila, A., Ouwehand, A. C., et al. (2022). Role of D-mannose in urinary tract infections – a narrative review. Nutritional Journal, 21(1), 18. https://doi.org/10.1186/s12937-022-00769-x
Al-Fadhli, A. H., & Jamal, W. Y. (2024). Recent advances in gene-editing approaches for tackling antibiotic resistance threats: A review. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1410115
Aljabali AAA, El-Tanani M, Tambuwala MM. Principles of CRISPR-Cas9 technology: Advancements in genome editing and emergeng trends in drug delivery. Journal of Drug Delivery Science and Technology, 2024; 92:105338.
Alshomrani MK, Alharbi AA, Alshehri AA, Arshad M, Dolgum S, Alshomrani M, et al. (2023). Isolation of Staphylococcus aureus Urinary Tract Infections at a Community-Based Healthcare Center in Riyadh. Cureus ;15(2).
Armbruster, C. E., Mobley, H. L. T., & Pearson, M. M. (2018). Pathogenesis of Proteus mirabilis Infection. EcoSal Plus, 8(1), 10.1128/ecosalplus.ESP-0009-2017. https://doi.org/10.1128/ecosalplus.ESP-0009-2017
Baimakhanova, B., Sadanov, A., Trenozhnikova, L., Balgimbaeva, A., Baimakhanova, G., Orasymbet, S., Tleubekova, D., Amangeldi, A., Turlybaeva, Z., Nurgaliyeva, Z., Seisebayeva, R., Kozhekenova, Z., Sairankyzy, S., Shynykul, Z., Yerkenova, S., & Turgumbayeva, A. (2025). Understanding the Burden and Management of Urinary Tract Infections in Women. Diseases (Basel,Switzerland), 13(2), 59. https://doi.org/10.3390/diseases13020059
Belyayeva, M., Leslie, S. W., & Jeong, J. M. (2024). Acute pyelonephritis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK519537/
Bingshuo Yan, Yuting Li, Shiming He. (2024). Aptamer-mediated therapeutic strategies provide a potential approach for cancer. International Immunopharmacology, Volume 136, 112356
Bono, M. J., Leslie, S. W., & Reygaert, W. C. (2023). Uncomplicated urinary tract infections. In StatPearls. StatPearls Publishing.
Braczkowska M, Glinka L, Mieszkowski M, Tuyakov B, Gutysz-Wojnicka A. (2020). Septic shock caused by community-acquired urinary tract infection caused by Klebsiella pneumoniae ESBL+: A case report. Polish Annals of Medicine ;27(2):168-73.
Calin, R., Hafner, J., & Ingersoll, M. A. (2024). Immunity to urinary tract infection: What the clinician should know. CMI Communications, 1(3), 105057. https://doi.org/10.1016/j.cmicom.2024.105057
Chen J, Zhou J, Peng Y, Xie Y, Xiao Y (2022). Aptamers: A prospective tool for diagnosis of infectious diseases. J Clin Lab Anal;36(11):e24725. doi:10.1002/jcla.24725
Chen, S., Mao, Q., Cheng, H., & Tai, W. (2024). RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals. Journal of Medicinal Chemistry, 67(18), 16002–16017. https://doi.org/10.1021/acs.jmedchem.4c01330
Chinni, S. V., Raabe, C. A., Zakaria, R., Randau, G., Hoe, C. H., Zemann, A., Brosius, J., Tang, T. H., & Rozhdestvensky, T. S. (2010). Experimental identification and characterization of 97 novel npcRNA candidates in Salmonella enterica serovar Typhi. Nucleic acids research, 38(17), 5893–5908. https://doi.org/10.1093/nar/gkq281
Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. (2021)Urinary tract infection in women. Menopausal Review;20(1):40–7.
Deal, C. E., Carfi, A., & Plante, O. J. (2021). Advancements in mRNA Encoded Antibodies for Passive Immunotherapy. Vaccines, 9(2), 108. https://doi.org/10.3390/vaccines9020108
Delgado, G., McReynolds, A. K. G., Pagella, E. A., Norambuena, J., Briaud, P., Zheng, V., Munneke, M. J., Kim, J., Racine, H., Carroll, R., Zelzion, E., Skaar, E., Bose, J. L., Parker, D., Lalaouna, D., & Boyd, J. M. (2024). The Staphylococcus aureus small non-coding RNA IsrR regulates TCA cycle activity and virulence. bioRxiv, the preprint server for biology, 2024.07.03.601953. https://doi.org/10.1101/2024.07.03.601953
Deltourbe L, Lacerda Mariano L, Hreha TN, Hunstad DA, Ingersoll MA (2022). The impact of biological sex on diseases of the urinary tract. Mucosal Immunology. May;15(5):857–66.
Eman Muftah Elzouki1, Salwa Muftah Eljamay2, Salma Awad Elzouki3, (2023). Isolation and Identification of S. aureus in Urinary Tract Infection. Indonesian Journal of Community Services, 2(2): 53-59.
Finlayson, J., Gore, N., Ord, P., Roche, F., Butcher, J., Kean, R., & Skelton, D. A. (2025). Urinary Tract Infections Amongst Adults with Intellectual Disabilities With Urinary Incontinence. Journal of Applied Research in Intellectual Disabilities, 38(1), e13317. https://doi.org/10.1111/jar.13317
Gopinath, S.C.B., Ramanathan, S., Chinni, S.V. et al. (2022). Non-protein coding RNA sequences mediate specific colorimetric detection of Staphylococcus aureus on unmodified gold nanoparticles. Sci Rep 12, 12621.
Haseltine, W. A., & Patarca, R. (2024). The RNA Revolution in the Central Molecular Biology Dogma Evolution. International Journal of Molecular Sciences, 25(23), 12695. https://doi.org/10.3390/ijms252312695
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023). Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options. Antibiotics (Basel, Switzerland), 12(2), 234. https://doi.org/10.3390/antibiotics12020234
Kim, YK. (2022). RNA therapy: rich history, various applications, and unlimited future prospects. Exp Mol Med 54, 455–465.
Kishanraj, S., Sumitha, S., Tang, T. H., Citartan, M., & Chinni, S. V. (2021). Comparative genomic identification and characterization of npcRNA homologs in Proteus vulgaris. Journal of biosciences, 46, 108.
Klein RD, Hultgren SJ. (2020). Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nature Reviews Microbiology ;18(4):211–26.
Kot, B., Piechota, M., Szweda, P., Mitrus, J., Wicha, J., Grużewska, A., & Witeska, M. (2023). Virulence analysis and antibiotic resistance of Klebsiella pneumoniae isolates from hospitalised patients in Poland. Scientific Reports, 13(1), 4448. https://doi.org/10.1038/s41598-023-31086-w
Kwok Jian Goh, Yael Altuvia, Liron Argaman, Yair Raz, Amir Bar, Trevor Lithgow, Hanah Margalit, Yunn-Hwen Gan. (2024). RIL-seq reveals extensive involvement of small RNAs in virulence and capsule regulation in hypervirulent Klebsiella pneumoniae, Nucleic Acids Research, Volume 52, Issue 15,4, Pages 9119–9138, https://doi.org/10.1093/nar/gkae440
Lauffer, M. C., van Roon-Mom, W., Aartsma-Rus, A., & N = 1 Collaborative. (2024). Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Communications Medicine, 4(1), 6. https://doi.org/10.1038/s43856-023-00419-1
Li, Y., & Ni, M. (2023). Regulation of biofilm formation in Klebsiella pneumoniae. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1238482
Lila ASA, Rajab AAH, Abdallah MH, Rizvi SMD, Moin A, Khafagy ES, et al.(2023). Biofilm Lifestyle in Recurrent Urinary Tract Infections. Life, 1;13(1):148.
Loh, E., Righetti, F., Eichner, H., Twittenhoff, C., & Narberhaus, F. (2018). RNA Thermometers in Bacterial Pathogens. Microbiology Spectrum, 6(2), 6.2.13. https://doi.org/10.1128/microbiolspec.RWR-0012-2017
Mak, Q., Greig, J., Dasgupta, P., Malde, S., & Raison, N. (2024). Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-analysis. European Urology Focus, 10(5), 761–769. https://doi.org/10.1016/j.euf.2024.04.002
Maldonado-Barrueco, A., Grandioso-Vas, D., Rico-Nieto, A., García-Rodríguez, J., & García-Bujalance, S. (2022). The Briefcase: Proteus mirabilis Causing Coraliform Lithiasis and Bacteremia in an Elderly Catheterized Patient. Journal of clinical microbiology, 60(10), e0241321. https://doi.org/10.1128/jcm.02413-21
Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. (2023). Urinary Tract Infections:The Current Scenario and Future Prospects. Pathogens;12(4):623.
Mihaita, A., Robinson, A., Costello, E., Marino, M., Mrozek, Z., Long, L., Fogarty, A., Egan, M., & Bhatt, S. (2025). The RNA chaperone protein ProQ is a pleiotropic regulator in enteropathogenic Escherichia coli. Microbial Pathogenesis, 199, 107153.
Motamedi, H., Ari, M. M., Alvandi, A., & Abiri, R. (2024). Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: A comprehensive review. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1393646
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023). Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals (Basel, Switzerland), 16(11), 1615. https://doi.org/10.3390/ph16111615
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., Hsu, R. L., Chalek, J., Araki, D. T., Chung, E., Raggi, C., Gershberg Hayoon, A., Davis Weaver, N., Lindstedt, P. A., Smith, A. E., Murray, C. J. L. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1
Nemeth, K., Bayraktar, R., Ferracin, M. et al. (2024). Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25, 211–232. https://doi.org/10.1038/s41576-023-00662-1
Norsworthy, A. N., & Pearson, M. M. (2017). From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis. Trends in Microbiology, 25(4), 304–315. doi:10.1016/j.tim.2016.11.015
Olenginski, L. T., Spradlin, S. F., & Batey, R. T. (2024). Flipping the script: Understanding riboswitches from an alternative perspective. Journal of Biological Chemistry, 300(3), 105730. https://doi.org/10.1016/j.jbc.2024.105730
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., & Song, X. (2022). mRNA-based therapeutics: Powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy, 7(1), 166. https://doi.org/10.1038/s41392-022-01007-w
Sgarabotto, D., Andretta, E., & Sgarabotto, C. (2025). Recurrent Urinary Tract Infections (UTIs): A Review and Proposal for Clinicians. Antibiotics, 14(1), 22. https://doi.org/10.3390/antibiotics14010022
Sharma, S., Houfani, A. A., & Foster, L. J. (2024). Pivotal functions and impact of long con-coding RNAs on cellular processes and genome integrity. Journal of Biomedical Science, 31(1), 52. https://doi.org/10.1186/s12929-024-01038-1
Singh, S., Kumari, N., Dutta, T., & Karmakar, T. (2025). Understanding RNA Chaperone Activity of ProQ Protein. bioRxiv
Smith DA, Nehring SM. Bacteremia. (2023). Nih.gov. StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK441979/
Subhadra, B., & Sarshar, M. (2024). Editorial: Small non-coding RNAs in Gram negative bacteria. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1426124
Sun, H., Wang, M., Liu, Y., Wu, P., Yao, T., Yang, W., Yang, Q., Yan, J., & Yang, B. (2022). Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7. Gut microbes, 14(1), 2110822. https://doi.org/10.1080/19490976.2022.2110822
Tian, L., Gao, C., Lu, J., Liao, S., & Gong, G. (2024). Key biological processes and essential genes for Proteus mirabilis biofilm development inhibition by protocatechuic acid. International Journal of Food Microbiology, 412, 110570. https://doi.org/10.1016/j.ijfoodmicro.2024.110570
Wang, M. F. Z., Mantri, M., Chou, S. P., et al. (2021). Uncovering transcriptional dark matter via gene annotation independent
single-cell RNA sequencing analysis. Nature Communications, 12(1), 2158. https://doi.org/10.1038/s41467-021-22496-3
Wasfi, R., Hamed, S. M., Amer, M. A., & Fahmy, L. I. (2020). Proteus mirabilis Biofilm: Development and Therapeutic Strategies. Frontiers in cellular and infection microbiology, 10, 414. https://doi.org/10.3389/fcimb.2020.00414
WHO. (2023) Antimicrobial Resistance. World Health Organization. WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
Xu K, Wang Y, Jian Y, et al. (2023). Staphylococcus aureus ST1 promotes persistent urinary tract infection by highly expressing the urease. Front Microbiol. 14:1101754
Yamamoto H, Hashimoto K, Yamada H, Ikeda Y, Takahashi T, Hashimoto T. (2022). Case Report: Methicillin-Resistant Staphylococcus aureus Endocarditis Overlying Calcified Mitral Annular Abscess Misdiagnosed as Klebsiella pneumoniae Endocarditis.” Frontiers in Microbiology;12.
Zagaglia C, Ammendolia MG, Maurizi L, Nicoletti M, Longhi C. (2022). Urinary Tract Infections Caused by Uropathogenic Escherichia coli Strains. New Strategies for an Old Pathogen. Microorganisms;10(7):1425.
Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, et al. (2023). Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options. International Journal of Molecular Sciences;24(13):10537–7.
Zhu Y, Zhu L, Wang X, Jin H. (2022). RNA-based therapeutics: an overview and prospectus. Cell Death & Disease;13(7):1–15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Malaysian Journal of Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Transfer of Copyrights
- In the event of publication of the manuscript entitled [INSERT MANUSCRIPT TITLE AND REF NO.] in the Malaysian Journal of Science, I hereby transfer copyrights of the manuscript title, abstract and contents to the Malaysian Journal of Science and the Faculty of Science, University of Malaya (as the publisher) for the full legal term of copyright and any renewals thereof throughout the world in any format, and any media for communication.
Conditions of Publication
- I hereby state that this manuscript to be published is an original work, unpublished in any form prior and I have obtained the necessary permission for the reproduction (or am the owner) of any images, illustrations, tables, charts, figures, maps, photographs and other visual materials of whom the copyrights is owned by a third party.
- This manuscript contains no statements that are contradictory to the relevant local and international laws or that infringes on the rights of others.
- I agree to indemnify the Malaysian Journal of Science and the Faculty of Science, University of Malaya (as the publisher) in the event of any claims that arise in regards to the above conditions and assume full liability on the published manuscript.
Reviewer’s Responsibilities
- Reviewers must treat the manuscripts received for reviewing process as confidential. It must not be shown or discussed with others without the authorization from the editor of MJS.
- Reviewers assigned must not have conflicts of interest with respect to the original work, the authors of the article or the research funding.
- Reviewers should judge or evaluate the manuscripts objective as possible. The feedback from the reviewers should be express clearly with supporting arguments.
- If the assigned reviewer considers themselves not able to complete the review of the manuscript, they must communicate with the editor, so that the manuscript could be sent to another suitable reviewer.
Copyright: Rights of the Author(s)
- Effective 2007, it will become the policy of the Malaysian Journal of Science (published by the Faculty of Science, University of Malaya) to obtain copyrights of all manuscripts published. This is to facilitate:
- Protection against copyright infringement of the manuscript through copyright breaches or piracy.
- Timely handling of reproduction requests from authorized third parties that are addressed directly to the Faculty of Science, University of Malaya.
- As the author, you may publish the fore-mentioned manuscript, whole or any part thereof, provided acknowledgement regarding copyright notice and reference to first publication in the Malaysian Journal of Science and Faculty of Science, University of Malaya (as the publishers) are given. You may produce copies of your manuscript, whole or any part thereof, for teaching purposes or to be provided, on individual basis, to fellow researchers.
- You may include the fore-mentioned manuscript, whole or any part thereof, electronically on a secure network at your affiliated institution, provided acknowledgement regarding copyright notice and reference to first publication in the Malaysian Journal of Science and Faculty of Science, University of Malaya (as the publishers) are given.
- You may include the fore-mentioned manuscript, whole or any part thereof, on the World Wide Web, provided acknowledgement regarding copyright notice and reference to first publication in the Malaysian Journal of Science and Faculty of Science, University of Malaya (as the publishers) are given.
- In the event that your manuscript, whole or any part thereof, has been requested to be reproduced, for any purpose or in any form approved by the Malaysian Journal of Science and Faculty of Science, University of Malaya (as the publishers), you will be informed. It is requested that any changes to your contact details (especially e-mail addresses) are made known.
Copyright: Role and responsibility of the Author(s)
- In the event of the manuscript to be published in the Malaysian Journal of Science contains materials copyrighted to others prior, it is the responsibility of current author(s) to obtain written permission from the copyright owner or owners.
- This written permission should be submitted with the proof-copy of the manuscript to be published in the Malaysian Journal of Science
Licensing Policy
Malaysian Journal of Science is an open-access journal that follows the Creative Commons Attribution-Non-commercial 4.0 International License (CC BY-NC 4.0)
CC BY – NC 4.0: Under this licence, the reusers to distribute, remix, alter, and build upon the content in any media or format for non-commercial purposes only, as long as proper acknowledgement is given to the authors of the original work. Please take the time to read the whole licence agreement (https://creativecommons.org/licenses/by-nc/4.0/legalcode ).
